Impact of gestational treatment or prenatal cocaine exposure on early postpartum oxytocin synthesis and receptor binding

Prior research reported decreased oxytocin levels in specific brain regions and disruptions in maternal care following gestational cocaine treatment in rats. Similarly, prenatal exposure to cocaine impaired maternal behavior in adulthood, but this was not associated with oxytocin level disruptions. To determine if cocaine alters other aspects of the oxytocin system, oxytocin mRNA transcription and receptor binding were examined on postpartum day two in relevant brain regions following gestational treatment with, or prenatal exposure to, either cocaine or saline. Results indicated an increase in oxytocin mRNA levels in the paraventricular nucleus of dams treated with cocaine gestationally with no group differences in brain regions dependent upon prenatal exposure. No significant differences in receptor binding were found in any region examined for either group of dams. These findings suggest that cocaine affects multiple aspects of the oxytocin system in the early postpartum that could be associated with altered maternal behavior

Exercise-Induced Glycogen Reduction Increases Muscle Activity

International Journal of Exercise Science 9(3): 336-346, 2016. Intramuscular glycogen stores are an important energy source during extended bouts of strenuous exercise. A substantial reduction in glycogen could influence neural muscular drive and result in a decreasing quality of exercise performance and potentially increased injury rates. The aim of this study was to examine the effect of glycogen reduction on motor drive as determined by the surface electromyogram (EMG) amplitude and median frequency during a cycling graded exercise test. Eight trained cyclists performed a discontinuous cycling graded exercise test to exhaustion under both normal and glycogen reduced conditions. EMG was collected from the vastus lateralis. Repeated measures regression models indicated that EMG amplitudes were elevated at cycling workloads higher than 196 Watts and metabolic workloads higher than 40.8 ml/kg/min, corresponding to 77% VO2max. There was no effect of increases in workload or glycogen reduction on EMG median frequency. Changes in mechanical and metabolic workload had a substantial effect on EMG amplitude (Cohen’s f2 = 0.227 and 0.247, respectively), but not median frequency (Cohen’s f2 = 0.026 and 0.033, respectively). Thus, EMG amplitude is a more effective and reliable measure to examine changes in motor drive during variable workload conditions and metabolic perturbations. The results suggest that healthy glycogen reduced humans require higher levels of muscle activity in order to attain a given mechanical and metabolic workload. This may affect the long term performance of professional and military athletes who need to be able to perform at a high level for extended periods of activity

A novel device for the calibration of sonic and ultrasonic recording transducers

Recently, there has been an increase in the analysis of animal vocalizations in behavioral neuroscience as a social cue or indicator of neurological integrity. Despite the multitude of researchers examining vocalizations in a variety of species, no inexpensive, tunable devices currently exist to calibrate the amplification applied to such vocalizations before data are collected. Many commercially available recording systems have analogue adjustments for gain, but such methods are notoriously unreliable and highly variable. Without a consistent level of gain, the amplitudes of recorded acoustic signals cannot be reliably compared. Here, we describe an apparatus designed to fulfill this need, which we have labeled the Calibration Unit for Recording Transducers (CURT). To maximize application to various fields, its emitted frequency and amplitude are tunable to output frequencies in both human-sonic (20 Hz – 20 kHz) and human-ultrasonic ranges (20–100 kHz). Additionally, it is a portable (weighing approximately 180 g), customizable, stand-alone unit, and fits a variety of microphone connector types. The CURT is also relatively low cost to build (under 250.00 USD), thereby making such a device available to as many researchers as possible in animal behavior and neuroscience

Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005

Background: Improvements in stroke management have led to increases in the numbers of stroke survivors over the last decade and there has been a corresponding increase of hospital readmissions after an initial stroke hospitalisation. The aim of this study was to examine the one year risk of having a readmission due to infective, gastrointestinal or immobility (IGI) complications and to identify temporal trends and any risk factors.<p></p> Methods: Using a cohort of first hospitalised for stroke patients who were discharged alive, time to first event (readmission for IGI complications or death) within 1 year was analysed in a competing risks framework using cumulative incidence methods. Regression on the cumulative incidence function was used to model the risks of having an outcome using the covariates age, sex, socioeconomic status, comorbidity, discharge destination and length of hospital stay.<p></p> Results: There were a total of 51,182 patients discharged alive after an incident stroke hospitalisation in Scotland between 1997–2005, and 7,747 (15.1%) were readmitted for IGI complications within a year of the discharge. Comparing incident stroke hospitalisations in 2005 with 1997, the adjusted risk of IGI readmission did not increase (HR = 1.00 95% CI (0.90, 1.11). However, there was a higher risk of IGI readmission with increasing levels of deprivation (most deprived fifth vs. least deprived fifth HR = 1.16 (1.08, 1.26).<p></p> Conclusions: Approximately 15 in 100 patients discharged alive after an incident hospitalisation for stroke in Scotland between 1997 and 2005 went on to have an IGI readmission within one year. The proportion of readmissions did not change over the study period but those living in deprived areas had an increased risk

Editorial: Why should we read Dalit literature?

<p>(A) BDNF and (B) NCAM1 expression in the VTA of mice exposed to ABA conditions. Insets indicate mean BDNF and NCAM1 expression during restriction for the independent measure depicted. Results expressed as mean log2(RQ) ± S.E.M. p<0.05. STV, starved mice exposed to food restriction and house without a wheel; RUN, mice exposed to wheel running; ABA, mice exposed to ABA conditions; W, wheel; FR, food restriction.</p

Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes

Purpose: The prevalence and consequences of prediabetic dysglycemia and undiagnosed diabetes is unknown in patients with heart failure (HF) and preserved ejection fraction (HFpEF) and has not been compared to heart failure and reduced ejection fraction (HFrEF). Methods: We examined the prevalence and outcomes associated with normoglycemia, prediabetic dysglycemia and diabetes (diagnosed and undiagnosed) among individuals with a baseline glycated hemoglobin (hemoglobin A1c, HbA1c) measurement stratified by HFrEF or HFpEF in the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity programme (CHARM). We studied the primary outcome of HF hospitalization or cardiovascular (CV) death, and all-cause death, and estimated hazard ratios (HR) by use of multivariable Cox regression models. Results: HbA1c was measured at baseline in CHARM patients enrolled in the USA and Canada and was available in 1072/3023 (35%) of patients with HFpEF and 1578/4576 (34%) patients with HFrEF. 18 and 16% had normoglycemia (HbA1c &lt; 6.0), 20 and 22% had prediabetes (HbA1c 6.0–6.4), respectively. Finally among patients with HFpEF 22% had undiagnosed diabetes (HbA1c &gt; 6.4), and 40% had known diabetes (any HbA1c), with corresponding prevalence among HFrEF patients being 26 and 35%. The rates of both clinical outcomes of interest were higher in patients with undiagnosed diabetes and prediabetes, compared to normoglycemic patients, irrespective of HF subtype, and in general higher among HFrEF patients. For the primary composite outcome among HFpEF patients, the HRs were 1.02 (95% CI 0.63–1.65) for prediabetes, HR 1.18 (0.75–1.86) for undiagnosed diabetes and 2.75 (1.83–4.11) for known diabetes, respectively, p value for trend across groups &lt; 0.001. Dysglycemia was also associated with worse outcomes in HFrEF. Conclusions: These findings confirm the remarkably high prevalence of dysglycemia in heart failure irrespective of ejection fraction phenotype, and demonstrate that dysglycemia is associated with a higher risk of adverse clinical outcomes, even before the diagnosis of diabetes and institution of glucose lowering therapy in patients with HFpEF as well as HFrEF

The Translational Role of Diffusion Tensor Image Analysis in Animal Models of Developmental Pathologies

Diffusion Tensor Magnetic Resonance Imaging (DTI) has proven itself a powerful technique for clinical investigation of the neurobiological targets and mechanisms underlying developmental pathologies. The success of DTI in clinical studies has demonstrated its great potential for understanding translational animal models of clinical disorders, and preclinical animal researchers are beginning to embrace this new technology to study developmental pathologies. In animal models, genetics can be effectively controlled, drugs consistently administered, subject compliance ensured, and image acquisition times dramatically increased to reduce between-subject variability and improve image quality. When pairing these strengths with the many positive attributes of DTI, such as the ability to investigate microstructural brain organization and connectivity, it becomes possible to delve deeper into the study of both normal and abnormal development. The purpose of this review is to provide new preclinical investigators with an introductory source of information about the analysis of data resulting from small animal DTI studies to facilitate the translation of these studies to clinical data. In addition to an in depth review of translational analysis techniques, we present a number of relevant clinical and animal studies using DTI to investigate developmental insults in order to further illustrate techniques and to highlight where small animal DTI could potentially provide a wealth of translational data to inform clinical researchers

Use of High Resolution 3D Diffusion Tensor Imaging to Study Brain White Matter Development in Live Neonatal Rats

High resolution diffusion tensor imaging (DTI) can provide important information on brain development, yet it is challenging in live neonatal rats due to the small size of neonatal brain and motion-sensitive nature of DTI. Imaging in live neonatal rats has clear advantages over fixed brain scans, as longitudinal and functional studies would be feasible to understand neuro-developmental abnormalities. In this study, we developed imaging strategies that can be used to obtain high resolution 3D DTI images in live neonatal rats at postnatal day 5 (PND5) and PND14, using only 3 h of imaging acquisition time. An optimized 3D DTI pulse sequence and appropriate animal setup to minimize physiological motion artifacts are the keys to successful high resolution 3D DTI imaging. Thus, a 3D rapid acquisition relaxation enhancement DTI sequence with twin navigator echoes was implemented to accelerate imaging acquisition time and minimize motion artifacts. It has been suggested that neonatal mammals possess a unique ability to tolerate mild-to-moderate hypothermia and hypoxia without long term impact. Thus, we additionally utilized this ability to minimize motion artifacts in magnetic resonance images by carefully suppressing the respiratory rate to around 15/min for PND5 and 30/min for PND14 using mild-to-moderate hypothermia. These imaging strategies have been successfully implemented to study how the effect of cocaine exposure in dams might affect brain development in their rat pups. Image quality resulting from this in vivo DTI study was comparable to ex vivo scans. fractional anisotropy values were also similar between the live and fixed brain scans. The capability of acquiring high quality in vivo DTI imaging offers a valuable opportunity to study many neurological disorders in brain development in an authentic living environment

Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial

Aims: The role of microvascular complications in the risk conferred by diabetes in heart failure with reduced ejection fraction (HFrEF) is unknown. Methods and results: We studied 2707 HFrEF patients in the Beta‐blocker Evaluation of Survival Trial (BEST), stratified into three groups: no diabetes and diabetes without or with microvascular complications (neuropathy, nephropathy, or retinopathy). The risks of the composite of cardiovascular death or heart failure hospitalization, and all‐cause death, were studied using Cox regression analyses adjusted for other prognostic variables. Overall, 964 (36%) patients had diabetes, of which 313 (32%) had microvascular complications. Patients with microvascular complications had more severe symptoms (New York Heart Association class IV 12% vs. 9% diabetes with no complications and 7% no diabetes), and worse quality of life (Minnesota Living with Heart Failure median score 60 vs. 54 and 51 points). In patients with diabetes and complications, the rate of the composite outcome was 50 per 100 person‐years of follow‐up (compared with 34 and 29 in those with diabetes and no microvascular complications and participants without diabetes, respectively). Compared to patients without diabetes, the adjusted hazard ratio (HR) for the composite outcome was 1.44 [95% confidence interval (CI) 1.22–1.70] and 1.18 (95% CI 1.03–1.35) for patients with diabetes with and without complications, respectively. The risk of all‐cause mortality was similarly elevated: adjusted HR 1.42 (95% CI 1.16–1.74) and 1.20 (95% CI 1.01–1.42), respectively. Conclusion: In HFrEF, diabetes with microvascular complications is associated with worse symptoms and outcomes than diabetes without microvascular complications. Prevention of microvascular complications has the potential to improve HFrEF outcomes